Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.06
(+0.15%)
USD |
NASDAQ |
May 20, 16:00
39.76
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Total Liabilities (Quarterly) : 154.42M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Apellis Pharmaceuticals, Inc. | 667.61M |
| Roivant Sciences Ltd. | 251.14M |
| Eli Lilly & Co. | 85.38B |
| Silence Therapeutics Plc | 65.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 641.76M |
| Shareholders Equity (Quarterly) | 487.35M |
| Debt to Equity Ratio | 0.2433 |
| Current Ratio | 9.534 |
| Net Debt Paydown Yield | -0.00% |